Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165995 | SCV000216753 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000228764 | SCV000288488 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000228764 | SCV000488814 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2016-06-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704208 | SCV000512508 | likely benign | not provided | 2019-07-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000165995 | SCV000684470 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001818387 | SCV002068111 | likely benign | not specified | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000228764 | SCV004019565 | benign | Hereditary diffuse gastric adenocarcinoma | 2023-03-03 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV003965211 | SCV004778354 | likely benign | CDH1-related disorder | 2022-12-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |